Author

Arjun A. Menon

Observed names: ARJUN A. MENON, Arjun Menon

Institution: Accenture (United States)

Observed institutions: University of Minnesota, NYU Langone Health, Accenture (United States), New York University

OpenAlex ID: A5110186126

Immune cell screening of a nanoparticle library improves atherosclerosis therapy

2016 · Jun Tang, Samantha Baxter, et al. · Proceedings of the National Academy of Sciences · 120

Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr−/− Mice

2017 · Mikyung Yu, Jaume Amengual, et al. · Advanced Healthcare Materials · 82

Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3)

2019 · Timothy S. Bailey, Jasmanda Wu, et al. · Diabetes Obesity and Metabolism · 33

Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world study

2019 · Sean D. Sullivan, Charlie J. Nicholls, et al. · Diabetes Obesity and Metabolism · 29

Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques

2016 · Paul F. Bradfield, Arjun Menon, et al. · PLoS ONE · 24

Thermal Injury Prediction During Cryoplasty Through In Vitro Characterization of Smooth Muscle Cell Biophysics and Viability

2007 · Saravana Kumar Balasubramanian, Ramji T. Venkatasubramanian, et al. · Annals of Biomedical Engineering · 23

Analysis of Hepatitis C Virus Particle Heterogeneity in Immunodeficient Human Liver Chimeric fah-/- Mice

2017 · Ursula Andreo, Ype P. de Jong, et al. · Cellular and Molecular Gastroenterology and Hepatology · 9

133-LB: High Hypoglycemia Risk Patients with T2D on First-Generation Basal Insulins (BI) in the U.S. Have a Lower Risk of Hypoglycemia after One Year following Switch to Insulin Glargine 300 U/mL (Gla-300) vs. First-Generation BIs (DELIVER - High Risk)

2019 · SEAN D. SULLIVAN, NICK FREEMANTLE, et al. · Diabetes · 4

135-LB: The Forgotten Populations: Real-World Patients with T2DM Not Meeting Eligibility Criteria of the Glargine 300 U/mL EDITION and BRIGHT RCTs

2019 · DIDAC MAURICIO, JUKKA WESTERBACKA, et al. · Diabetes · 1

Author response for "Switching to insulin glargine 300 units/mL in real‐world older type 2 diabetes patients (DELIVER 3)"

2019 · Timothy S. Bailey, Jasmanda Wu, et al. · Publons reviews and discussion

Works count: 10

Citation count: 325

H-index: 7

I10-index: 6